<DOC>
	<DOCNO>NCT00928291</DOCNO>
	<brief_summary>In study investigator aim test procalcitonin ( PCT ) - guide strategy allow reduce antibiotic use patient febrile neutropenia hospitalize Brazilian tertiary university hospital , cause harm .</brief_summary>
	<brief_title>Procalcitonin Protocol Shorten Antibiotic Therapy Febrile Neutropenia</brief_title>
	<detailed_description>Methods - Patients set : Prospective control randomized interventional study antibiotic therapy adult febrile neutropenia . The study conduct University Hospital Federal University Minas Gerais , Brazil . This 600-bed tertiary hospital , approximately 1.6 thousand hospitalizations/month . Roughly 120 episode febrile neutropenia record first semester 2007 , occur 100 patient hematological leucosis post-BMT . This number rise one considers group neutropenic patient , neutropenia due chemotherapy solid tumor , patient BM aplasia , myelo dysplasia , among others , - Interventions : As long core objective study test PCT-guided protocol allow guide antibiotic withdrawn neutropenic patient , patient febrile neutropenia antibiotic therapy include study . They submit follow exam : - Bood sample draw baseline blood culture , CRP , blood cell count , ion , liver profile renal function test . These exam repeat accord local protocol follow Service Hematology ( see appendix ) . - A plasma galactomannan test perform baseline patient consider inclusion study , repeat moment suspicion Aspergillus infection follow . - A chest radiography also perform participant baseline , accord clinical indication afterwards . - All patient abnormal chest radiography baseline submit contrasted chest CT ( without contrast creatinine clearance &lt; 50 ml/min ) . - Additional complementary exam perform clinically need . - Circulating PCT measurement perform baseline , day 3 ( initial PCT &lt; 0.5 ) day 5 ( initial PCT &gt; 0.5 ) . Eligible patient reassess day 3 ( initial PCT &lt; 0.5 ) day 5 ( initial PCT &gt; 0.5 ) , randomize 1:1 basis one two group since exclusion criterion ( see ) present time : Group 1 - PCT group : intervention antibiotic therapy base circulate PCT level . Group 2 - Control group : antibiotic therapy guide appropriate guideline , leave discretion caregiver . Patients randomize study undergo daily measurement plasma PCT level , keep antibiotic therapy relative reduction 90 % baseline PCT level , value lower 0.5 ng/ml reach , maintain additional 48h ( two measure ) . Therefore , plasma PCT level measure every 5 day 28th day follow-up death transference , either occurs first . Patients include interventional group observe least 48 hour follow antibiotic discontinuation discharge hospital . Extra PCT test perform accord clinical course . Apart antibiotic therapy , participant manage accord appropriate guideline . Patients febrile neutropenia hospitalize University Hospital Federal University Minas Gerais routinely care experienced hematology specialist together infectious disease consultant . This standard care offer patient include study . The final decision regard antibiotic therapy always let discretion specialist .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>age &gt; 18 year febrile neutropenia antibiotic therapy sign informed consent patient antibiotic therapy 72 hour inclusion patient post allogenic bonemarrow transplant ( BMT ) patient present one follow condition time randomization : severe mucositis alltrans retinoic acid ( ATRA ) syndrome disseminate intravascular coagulation hypotension ( systolic blood pressure &lt; 90 mmHg need vasopressor maintain blood pressure ) respiratory failure ( arterial oxygen pressure &lt; 60 mmHg breathing room air ) need mechanical ventilation severe renal failure require hemodialysis patient suspect ( positive galactomannan assay peripheral blood , nodular lesion halo chest CT ) microbiologically confirm fungal infection bacteremia due S. aureus microbiologically confirm carbapenem resistant P. aeruginosa A. baumanii infection microbiologically confirm pneumonia due P. aeruginosa , A. baumanii Stenotrophomonas maltophilla suspect confirmed infection cause atypical microorganism ( virus , parasite , P. jiroveci ) . Patients localize HSV infection ( e.g. , labial ) accept inclusion infection require prolonged therapy , endocarditis cerebral abscess clearly focal bacterial infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>procalcitonin</keyword>
	<keyword>neutropenia</keyword>
	<keyword>febrile neutropenia</keyword>
	<keyword>antibiotic therapy</keyword>
	<keyword>neutropenic patient</keyword>
</DOC>